Health Care & Life Sciences » Pharmaceuticals | Luye Pharma Group Ltd.

Luye Pharma Group Ltd. | Ownership

Companies that own Luye Pharma Group Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
UBS AG (Investment Management)
107,975,001
3.3%
107,975,001
0.08%
09/03/2018
First State Investments (Hong Kong) Ltd.
87,787,500
2.68%
42,000
0.76%
01/31/2018
The Vanguard Group, Inc.
54,118,598
1.65%
1,917,500
0%
07/31/2018
Templeton Asset Management Ltd. (Hong Kong)
29,851,100
0.91%
-2,043,500
0.17%
06/30/2018
UBS Asset Management (Hong Kong) Ltd.
23,397,116
0.71%
0
0.5%
01/31/2018
BlackRock Fund Advisors
23,091,000
0.71%
0
0%
09/06/2018
Templeton Asset Management Ltd.
22,107,000
0.68%
-7,701,500
0.7%
06/30/2018
OrbiMed Advisors LLC
21,121,416
0.65%
-237,363
0.21%
09/30/2017
Dimensional Fund Advisors LP
16,458,500
0.5%
-22,000
0%
04/30/2018
APG Asset Management NV
8,996,708
0.28%
-1,127,987
0.01%
03/31/2018

About Luye Pharma Group

View Profile
Address
No. 15 Chuang Ye Road
Yantai Shandong 264003
China
Employees -
Website http://www.luye.cn
Updated 07/08/2019
Luye Pharma Group Ltd. is an investment holding company, which engages in the developing, producing, marketing, and selling pharmaceutical products. It operates through the following segments: Oncology Drugs, Cardiovascular System Drugs, Alimentary Tract and Metabolism Drugs, and Others. The company was founded on June 8, 1994 and is headquartered in Yantai, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.